Swiss drugmaker Novartis on Sunday said it agreed to acquire US biotech firm Avidity Biosciences for about $12 billion in cash, as the company looks to bolster its portfolio of treatments for rare muscle disorders. Avidity stockholders will receive...
Swiss drugmaker Novartis on Sunday said it agreed to acquire US biotech firm Avidity Biosciences for about $12 billion in cash, as the company looks to bolster its portfolio of treatments for rare muscle disorders. Avidity stock...
The $1.25 billion refinancing of 3 Bryant Park last February wasn’t only good news for owner Ivanhoe Cambridge and the 1.2 million square-foot office tower. Drew Isaacson, part of the JLL capital markets team that arranged the r...
Mikie Sherrill, once comfortably ahead in the New Jersey governor’s race, has been getting plenty of attention over her stock trading lately, and not in a good way. Her fellow lawmakers should take note if they also have aspirat...
WASHINGTON — The US and China have finalized a deal to transfer the American version of TikTok to new owners, Treasury Secretary Scott Bessent revealed on Sunday. President Trump and Chinese leader Xi Jinping will officially “...
Dow closes at all-time high as US inflation rises to just 3% in September — paving way for rate cuts
US inflation ticked up in September to 3% — a slightly lower than expected number that paves the way for the Federal Reserve to cut rates at its policy meeting next week. In a report that got delayed more than a week because of ...
CNN anchor Christiane Amanpour revealed she is once again battling ovarian cancer — four years after her first diagnosis — and urged women to pay attention to warning signs. The veteran journalist disclosed that the disease ha...